Glimepiride Tablet Market

Glimepiride Tablet Market, Global Outlook and Forecast 2022-2028

SR1149069 | 28-Jul-2022 | 78 Pages | Market Monitor Global |

Summary


Glimepiride, is an anti-diabetic medication used to treat type 2 diabetes.
This report contains market size and forecasts of Glimepiride Tablet in global, including the following market information:
Global Glimepiride Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glimepiride Tablet Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Glimepiride Tablet companies in 2021 (%)
The global Glimepiride Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
3 Blisters/Box Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glimepiride Tablet include The Perrigo Company, Hoechst Marion Roussel, Elikem Pharmaceuticals Private Limited, Sanofi, Physicians Total Care, Inc, Apotex, Sandoz, Avera and St. Marys, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glimepiride Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glimepiride Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Glimepiride Tablet Market Segment Percentages, by Type, 2021 (%)
3 Blisters/Box
10 Blisters/Box
Global Glimepiride Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Glimepiride Tablet Market Segment Percentages, by Application, 2021 (%)
People With Mild Diabetes
Patients With Severe Diabetes
Global Glimepiride Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Glimepiride Tablet Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glimepiride Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glimepiride Tablet revenues share in global market, 2021 (%)
Key companies Glimepiride Tablet sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Glimepiride Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
The Perrigo Company
Hoechst Marion Roussel
Elikem Pharmaceuticals Private Limited
Sanofi
Physicians Total Care, Inc
Apotex
Sandoz
Avera
St. Marys
RemedyRepack
CorePharma LLC
Glaxosmithkline Inc

Recommendations

Pharmaceuticals and Healthcare

BNCT Boron Drug Market, Global Outlook and Forecast 2022-2028

Published : Jul-2022

Pharmaceuticals and Healthcare

Sore Throat Lozenges Market, Global Outlook and Forecast 2022-2028

Published : Jul-2022

Pharmaceuticals and Healthcare

Digestive Enzyme Complexs Market, Global Outlook and Forecast 2022-2028

Published : Jul-2022

Pharmaceuticals and Healthcare

Botrytis Tests Market, Global Outlook and Forecast 2022-2028

Published : Jul-2022

Pharmaceuticals and Healthcare

Glimepiride Tablet Market, Global Outlook and Forecast 2022-2028

Published : Jul-2022

Pharmaceuticals and Healthcare

Glutathione Tablet Market, Global Outlook and Forecast 2022-2028

Published : Jul-2022

Need specific information?

Request Customization

Explore Pharmaceuticals and Healthcare Insights

View Reports
Logo

Statzy Market Research

Hi there 👋

How can I help you?
×
Chat with Us